 IRVINE, Calif., Aug. 27, 2021 GLOBE NEWSWIRE -- Biomerica, Inc. Nasdaq: BMRA, the Company a global provider of advanced medical products, today reported its fiscal 2021 financial results. During the year the Company made significant progress in its business by increasing its number of allowed patents covering its InFoods diagnostic guided therapy technology, signing a distribution agreement for its H. Pylori product which is expected to be filed with FDA in October, 2021, and has entered into negotiations with major retailersdistributors for sales of its EZ Detect colorectal disease test. 